| Title | Date | PubMed ID |
|---|
| Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain. | 2014 Feb | 24184653 |
| Effect of the ILE86TER mutation in the γ subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling. | 2012 Jan | 21920434 |
| shRNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa. | 2011 Aug | 20950332 |
| Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1. | 2011 Mar | 21282562 |
| Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. | 2010 Nov | 20493887 |
| In vitro interaction of tubulin with the photoreceptor cGMP phosphodiesterase gamma-subunit. | 2010 Oct 4 | 20655363 |
| A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia. | 2010 Sep | 20184577 |
| Mechanism for the regulation of mammalian cGMP phosphodiesterase6. 2: isolation and characterization of the transducin-activated form. | 2010 Jun | 20177739 |
| Mechanism for the regulation of mammalian cGMP phosphodiesterase6. 1: identification of its inhibitory subunit complexes and their roles. | 2010 Jun | 20151179 |
| 1-(2-(2,2,2-trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors. | 2010 May 15 | 20400309 |